Pharmaceutical Industry Information Portal

HomeTagsInvestments

All posts by tag

Investments

Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug

A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying its Breyanzi cancer drug to...

Gurnet Point Capital, Patient Square Capital agreed to pay up to $890 million for biotechnology

Radius Health, a maker of bone and cancer drugs, has agreed to be taken private in an acquisition worth up to $890 million, announcing...

AVEO Oncology signs collaboration and supply agreement with Eli Lilly

AVEO Oncology Inc. said it has entered into a clinical trial collaboration and supply agreement in North America with Eli Lilly & Co. to...

Novartis loses over $2.7 billion in patent appeal of multiple sclerosis drug

A U.S. appeals court on Tuesday ruled that a patent related to Swiss drugmaker Novartis AG's blockbuster multiple sclerosis drug Gilenya was invalid, potentially...

Alladapt announces $119M institutional financing to support ongoing clinical development

Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, announced today the closing of a $119 million...

ResApp stock returned from trading halt, down 29%

The ResApp Health Ltd share price has returned from its trading halt and taken a tumble. In morning trade, the digital health company’s shares...
spot_img

Expert Articles

spot_img